Ruxolitinib Impurity 30 | CAS 2183286-19-1 - Request Quote
Ruxolitinib Impurity 30
| SZ CAT No: | SZ-R044055 |
| CAS No | 2183286-19-1 |
| Mol.F. | C11H14BrN3 |
| Mol.Wt. | 268.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ruxolitinib Impurity 30 is chemically (S)-3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile. Ruxolitinib Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Ruxolitinib Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ruxolitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2183286-19-1
Purchase 2183286-19-1
Order 2183286-19-1
Enquire 2183286-19-1
price of 2183286-19-1
2183286-19-1 Supplier
2183286-19-1 Manufacturer
2183286-19-1 Exporter
buy high quality Ruxolitinib Impurity 30
Purchase Ruxolitinib Impurity 30
Ruxolitinib Impurity 30 suppliers
Ruxolitinib Impurity 30 manufacturers
Ruxolitinib Impurity 30 price
Order Ruxolitinib Impurity 30
Enquire Ruxolitinib Impurity 30
Ruxolitinib Impurity 30 cost
Ruxolitinib Impurity 30 Supplier
Ruxolitinib Impurity 30 Distributor
Ruxolitinib Impurity 30 for Method Validation
Ruxolitinib Reference Standard
Ruxolitinib Impurity 30 for ANDA Filing
Ruxolitinib Impurity 30 for Forced Degradation Studies
Ruxolitinib Impurity 30 Identification Standards
Ruxolitinib Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


